IMPROVEMENTS IN QUALITY OF LIFE IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

被引：0
|
作者：
Hatemi, Gulen [1 ]
Mahr, Alfred [2 ]
Takeno, Mitsuhiro [3 ]
Kim, Doyoung [4 ]
Melikoglu, Melike [5 ]
Cheng, Sue [6 ]
Mccue, Shannon [6 ]
Paris, Maria [6 ]
Chen, Mindy [6 ]
Yazici, Yusuf [7 ]
机构：
[1] Istanbul Univ Cerrahpasa, Med, Istanbul, Turkey
[2] St Louis Hosp, Paris, France
[3] Nippon Med Sch, Bunkyo Ku, Tokyo, Japan
[4] Yonsei Univ, Coll Med, Seoul, South Korea
[5] Istanbul Univ Cerrahpasa, Istanbul, Turkey
[6] Celgene Corp, Summit, NJ USA
[7] NYU, Sch Med, New York, NY USA
来源：
RHEUMATOLOGY | 2019年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
250
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Disease activity and quality-of-life improvements in patients with Behcet's syndrome: a phase III randomized, placebo-controlled, double-blind study of apremilast (RELIEF)
    Hatemi, G.
    Mahr, A.
    Ishigatsubo, Y.
    Song, Y. W.
    Melikoglu, M.
    Cheng, S.
    Mccue, S.
    Paris, M.
    Li, H.
    Yazici, Y.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S155 - S155
  • [2] Apremilast For The Treatment Of Behcet's Syndrome: A Phase II Randomized, Placebo-Controlled, Double-Blind Study
    Hatemi, Gulen
    Melikoglu, Melike
    Tunc, Recep
    Korkmaz, Cengiz
    Ozturk, Banu Turgut
    Mat, Cem
    Merkel, Peter A.
    Calamia, Kenneth
    Liu, Ziqi
    Pineda, Lilia
    Stevens, Randall M.
    Yazici, Hasan
    Yazici, Yusuf
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S322 - S322
  • [3] IMPROVEMENTS AND CORRELATIONS IN ORAL ULCERS, DISEASE ACTIVITY, AND QOL IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Hatemi, Gulen
    Mahr, Alfred
    Takeno, Mitsuhiro
    Kim, Doyoung
    Melikoglu, Melike
    Cheng, Sue
    Mccue, Shannon
    Paris, Maria
    Chen, Mindy
    Yazici, Yusuf
    RHEUMATOLOGY, 2019, 58 : 111 - 111
  • [4] Improvements and correlations in oral ulcers, disease activity, and quality of life in Behcet syndrome patients treated with apremilast: A phase III randomized, double-blind, placebo-controlled study (RELIEF)
    Hatemi, Gulen
    Mahr, Alfred
    Takeno, Mitsuhiro
    Kim, Do-Young
    Melikoglu, Melike
    Cheng, Sue
    McCue, Shannon
    Paris, Maria
    Chen, Mindy
    Yazici, Yusuf
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB78 - AB78
  • [5] APREMILAST FOR BEHCET'S SYNDROME: A PHASE III RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY (RELIEF)
    Hatemi, G.
    Mahr, A.
    Takeno, M.
    Kim, D. -Y.
    Melikoglu, M.
    Cheng, S.
    McCue, S.
    Paris, M.
    Wang, Y.
    Yazici, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 91 - 91
  • [6] Apremilast for the treatment of oral ulcers in Behcet's syndrome: a phase III randomized, double-blind, placebo-controlled study (RELIEF)
    Hatemi, G.
    Mahr, A.
    Takeno, M.
    Kim, D. Y.
    Melikoglu, M.
    Cheng, S.
    Mccue, S.
    Paris, M.
    Chen, M.
    Yazici, Y.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S177 - S177
  • [7] Apremilast for Behcet's syndrome: results from a phase III, randomized, double-blind, placebo-controlled study in a Japanese subgroup
    Kono, H.
    Dobashi, H.
    Tanaka, Y.
    Sugii, S.
    Kishimoto, M.
    Cheng, S.
    Mccue, S.
    Paris, M.
    Takeno, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S182 - S182
  • [8] Apremilast for Behcet's Syndrome: Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study in a Japanese Subgroup
    Takeno, Mitsuhiro
    Tanaka, Yoshiva
    Kono, Hajime
    Sugii, Shouji
    Kishimoto, Mitsumasa
    Chene, Sue
    McCue, Shannon
    Paris, Maria
    Dobashi, Hiroaki
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [9] APREMILAST FOR THE TREATMENT OF BEKET'S SYNDROME: A PHASE II RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
    Hatemi, G.
    Melikoglu, M.
    Tunc, R.
    Korkmaz, C.
    Ozturk, B. T.
    Mat, C.
    Merkel, P. A.
    Calamia, K. T.
    Liu, Z.
    Pineda, L.
    Stevens, R. M.
    Yazici, H.
    Yazici, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 486 - 486
  • [10] Apremilast in a Japanese subgroup with Behcet's syndrome: Results from a Phase 3, randomised, double-blind, placebo-controlled study
    Takeno, Mitsuhiro
    Dobashi, Hiroaki
    Tanaka, Yoshiya
    Kono, Hajime
    Sugii, Shouji
    Kishimoto, Mitsumasa
    Cheng, Sue
    McCue, Shannon
    Paris, Maria
    Chen, Mindy
    Ishigatsubo, Yoshiaki
    MODERN RHEUMATOLOGY, 2022, 32 (02) : 413 - 421
12345